September 27, 2016 12:20 AM ET

Pharmaceuticals

Company Overview of Iroko Pharmaceuticals Inc.

Key Executives for Iroko Pharmaceuticals Inc.

NameBoard RelationshipsTitleAge
Osagie O. Imasogie Esq.298 RelationshipsExecutive Chairman of the Board and Chief Executive Officer54
Fred C. Krieger MBA, CPANo RelationshipsSenior Vice President and Chief Financial Officer69
Moji James No RelationshipsSenior Vice President and General Counsel49
Clarence L. Young M.D.No RelationshipsSenior Vice President and Chief Medical Officer60
Rohit C. Mehta No RelationshipsSenior Vice President of Corporate Development and Alliance Management56

Iroko Pharmaceuticals Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Osagie O. Imasogie Esq. 298 RelationshipsIroko Pharmaceuticals Inc.54
Nathan A. Burkey 7 RelationshipsKew Capital LLP--
Jeremy P. A. Fletcher 15 RelationshipsKew Capital LLP62
David C. U'Prichard Ph.D. 125 RelationshipsDruid Consulting, LLC67
Louis J. Vollmer 5 RelationshipsIroko Pharmaceuticals, LLC--
View All Board Members

Iroko Pharmaceuticals Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
409.0K
Bonus
517.0K
Total Short Term Compensation
599.6K
Total Value of Options
14.4M
Compensation as of Fiscal Year
Iroko Pharmaceuticals Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Nouscom Announces Management Appointments
September 26, 2016 6:00 AM ET
Tyche Industries Ltd Announces the Resignation of G Sandeep as Whole Time Director and Chief Financial Officer
September 24, 2016 12:00 AM ET
Endo International plc Announces Executive Changes
September 23, 2016 11:00 AM ET
Gujarat Themis Biosyn Ltd. Announces Board Changes
September 23, 2016 10:41 AM ET
Merck KGaA Appoints Isabel De Paoli as Chief Strategy Officer, Effective 1 October 2016
September 23, 2016 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Iroko Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.